Please join Foley and Charles River Associates for a round table discussion with Zack Fang, member of the Chinese State Counsel Health Care Reform Expert Advisory Committee, and fellow panelists, to discuss:
- Myths about the Chinese health care system
- Competition and collaboration with local companies
- Opening China’s hospital market
- Price and market access issues faced by multinational pharmaceutical companies in China
Introduction
- Adria Warren, Senior Counsel, Foley & Lardner LLP
Moderator
- Dr. Elizabeth Xiao-Ru Wang, Principal, Charles River Associates
Panelists
- Dr. Jim Ewing, Partner, Foley & Lardner LLP
- Dr. Zack Fang, member of the Chinese State Counsel Health Care Reform Expert Advisory Committee
- Xiaolin Zhou, Partner, Jun He Law Offices
There is no cost to participate in this program; however, pre-registration is required. For additional information, please contact Delia Dai at [email protected].
People
Related Insights
19 September 2024
Viewpoints
SEC’s Focus on Whistleblower Protection Practices Continues
On September 9, 2024, the U.S. Securities and Exchange Commission announced that it settled charges against seven public companies for alleged violations of Securities Exchange Act Rule 21F-17.
19 September 2024
Manufacturing Industry Advisor
Cybersecurity in the Age of Industry 4.0 – Part 2
This is the second article in our two-part series on Cybersecurity in the Age of Industry 4.0, focusing on the legal implications and potential liabilities manufacturers face from cyberattacks, as well as practical recommendations to mitigate these risks.
19 September 2024
Viewpoints
FINRA In-House Disciplinary Proceedings Survive Post-Jarkesy Challenge … For Now
On September 4, 2024, the United States District Court for the Eastern District of Pennsylvania denied D. Allen Blankenship’s challenge to enjoin the Financial Industry Regulatory Authority’s disciplinary action against him.